ARVN
Price
$7.59
Change
-$0.20 (-2.57%)
Updated
Sep 25 closing price
Capitalization
496.28M
44 days until earnings call
Intraday BUY SELL Signals
PILL
Price
$16.76
Change
-$0.23 (-1.35%)
Updated
Sep 25 closing price
Net Assets
19.15M
Intraday BUY SELL Signals
Interact to see
Advertisement

ARVN vs PILL

ARVN vs PILL Comparison Chart in %
loading
loading
View a ticker or compare two or three
VS
ARVN vs. PILL commentary
Sep 27, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ARVN is a Hold and PILL is a Hold.

Interact to see
Advertisement
SUMMARIES
Loading...
FUNDAMENTALS RATINGS
ARVN: Fundamental Ratings
ARVN
OUTLOOK RATING
1..100
50
VALUATION
overvalued / fair valued / undervalued
1..100
79
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
83
PRICE GROWTH RATING
1..100
75
P/E GROWTH RATING
1..100
58
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ARVNPILL
RSI
ODDS (%)
Bullish Trend 3 days ago
84%
Bullish Trend 3 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 3 days ago
82%
Bullish Trend 3 days ago
89%
Momentum
ODDS (%)
Bearish Trend 3 days ago
85%
Bearish Trend 3 days ago
90%
MACD
ODDS (%)
Bearish Trend 3 days ago
84%
Bearish Trend 3 days ago
90%
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
83%
Bearish Trend 3 days ago
90%
TrendMonth
ODDS (%)
Bearish Trend 3 days ago
83%
Bearish Trend 3 days ago
90%
Advances
ODDS (%)
Bullish Trend 6 days ago
80%
Bullish Trend 6 days ago
90%
Declines
ODDS (%)
Bearish Trend 3 days ago
79%
Bearish Trend 17 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 3 days ago
90%
Bullish Trend 3 days ago
90%
Aroon
ODDS (%)
Bearish Trend 3 days ago
81%
Bearish Trend 3 days ago
90%
COMPARISON
Comparison
Sep 27, 2026
Stock price -- (ARVN: $7.59)
Brand notoriety:
Market capitalization --

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ARVN’s FA Score shows that 0 FA rating(s) are green while .

  • ARVN’s FA Score: 0 green, 5 red.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ARVN’s TA Score shows that 4 TA indicator(s) are bullish.

  • ARVN’s TA Score: 4 bullish, 6 bearish.

Price Growth

ARVN (@Biotechnology) experienced а -8.44% price change this weekfor the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -4.17%. For the same industry, the average monthly price growth was -13.24%, and the average quarterly price growth was +5.35%.

Reported Earning Dates

ARVN is expected to report earnings on Nov 10, 2026.

Industries' Descriptions

@Biotechnology (-4.17% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

View a ticker or compare two or three
ARVN
Daily Signal:
Gain/Loss:
PILL
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
HMY18.970.42
+2.26%
Harmony Gold Mining Company Limited
MNSBP24.980.23
+0.93%
MainStreet Bancshares
CBK32.090.28
+0.88%
Commercial Bancgroup Inc
CENT39.51N/A
N/A
Central Garden & Pet Company
PODC2.20-0.05
-2.22%
PodcastOne

PILL and

Correlation & Price change

A.I.dvisor indicates that over the last year, PILL has been loosely correlated with ARVN. These tickers have moved in lockstep 56% of the time. This A.I.-generated data suggests there is some statistical probability that if PILL jumps, then ARVN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PILL
1D Price
Change %
PILL100%
-1.35%
ARVN - PILL
56%
Loosely correlated
-2.57%
TRVI - PILL
55%
Loosely correlated
-1.81%
RAPP - PILL
53%
Loosely correlated
+0.24%
EWTX - PILL
51%
Loosely correlated
-4.42%
INDV - PILL
49%
Loosely correlated
-0.50%
More